0.9606  0.01 (1.09%)		09-11 16:00
Open: 0.9933 High: 0.9967 Volume: 99,709		Pre. Close: 0.9502 Low: 0.95 Market Cap: 2(M)

Short term
Mid term
Targets	6-month :	1.81	1-year :	2.26
Resists	First :	1.55	Second :	1.94
Pivot price	1.11
Supports	First :	0.93	Second :	0.78
MAs	MA(5) :	1.02	MA(20) :	1.12
	MA(100) :	1.56	MA(250) :	2.13
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	2.5	D(3) :	5.4
RSI	RSI(14): 41
52-week	High :	6.25	Low :	0.62

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CELZ ] has closed above bottom band by 7.5%. Bollinger Bands are 37.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	1 - 1	1 - 1.01
Low:	0.94 - 0.94	0.94 - 0.95
Close:	0.95 - 0.96	0.96 - 0.97

Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.

Thu, 20 Aug 2026
Creative Medical finishes treating back-pain patients who use opioids - Stock Titan

Thu, 06 Aug 2026
CELZ Stock Whipsaws As Traders Focus On Cash And Charts - StocksToTrade

Thu, 06 Aug 2026
Creative Medical receives patent allowance for diabetes exosome tech - Investing.com

Thu, 06 Aug 2026
Creative Medical Technology Holdings shares surge as traders appear to latch onto earlier pipeline updates and a tiny-float setup | CELZ Stock News - Quiver Quantitative

Wed, 01 Jul 2026
Creative Medical Technology Holdings Issues Mid-Year Update - manilatimes.net

Tue, 30 Jun 2026
Creative Medical Technology Holdings surges as traders appear to chase recent clinical and platform updates - Quiver Quantitative

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	0 (M)
Shares Float	7 (M)
Held by Insiders	6.56e+006 (%)
Held by Institutions	0.5 (%)
Shares Short	76 (K)
Shares Short P.Month	0 (K)

EPS	-6.13e+006
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-208 %
Return on Assets (ttm)	4.3 %
Return on Equity (ttm)	-47.4 %
Qtrly Rev. Growth	3000 %
Gross Profit (p.s.)	0
Sales Per Share	-38.18
EBITDA (p.s.)	985.29
Qtrly Earnings Growth	-2.1 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-6 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	-0.03
Price to Cash Flow	1.47

Dividend	0
Forward Dividend	584610
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.